OBJECTIVES: To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. METHODS: Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n = 23), and after CRT (n = 20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (k(ep)), elimination of contrast medium from the central compartment (k(el)) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. RESULTS: The pre-CRT AH between the responders and non-responders was significantly different (P = 0.046), however, the three parameters (TA, K(ep), K(el)) were not significantly different among the groups (P = 0.76, P = 0.60, P = 0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P = 0.043). CONCLUSION: The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.
OBJECTIVES: To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer. METHODS:Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n = 23), and after CRT (n = 20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (k(ep)), elimination of contrast medium from the central compartment (k(el)) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation. RESULTS: The pre-CRT AH between the responders and non-responders was significantly different (P = 0.046), however, the three parameters (TA, K(ep), K(el)) were not significantly different among the groups (P = 0.76, P = 0.60, P = 0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P = 0.043). CONCLUSION: The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.
Authors: Indira Madani; Wim Duthoy; Cristina Derie; Werner De Gersem; Tom Boterberg; Micky Saerens; Filip Jacobs; Vincent Grégoire; Max Lonneux; Luc Vakaet; Barbara Vanderstraeten; Wouter Bauters; Katrien Bonte; Hubert Thierens; Wilfried De Neve Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-01 Impact factor: 7.038
Authors: Anwar R Padhani; Carmel Hayes; Laura Assersohn; Trevor Powles; Andreas Makris; John Suckling; Martin O Leach; Janet E Husband Journal: Radiology Date: 2006-03-16 Impact factor: 11.105
Authors: Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph Salama; Everett E Vokes Journal: Laryngoscope Date: 2010-01 Impact factor: 3.325
Authors: P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff Journal: J Magn Reson Imaging Date: 1999-09 Impact factor: 4.813
Authors: T Chikui; E Kitamoto; Y Kami; S Kawano; K Kobayashi; T Kamitani; M Obara; K Yoshiura Journal: Br J Radiol Date: 2015-04-23 Impact factor: 3.039